amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye]
- RxCUI
- 1929118
- RxNorm name
- amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye]
- Display name
- amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye]
- Full name
- amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022175 | Pertzye | pancrelipase | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PERTZYE | PANCRELIPASE | Digestive Care, Inc. | 481eec00-9abf-11dd-b71c-0002a5d5c51b | 2024-03-11 | Warnings, Adverse reactions | 1929118 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 481eec00-9abf-11dd-b71c-0002a5d5c51b | Pertzye 24,000 UNT / 90,750 UNT / 86,250 UNT / Delayed Release Oral Capsule [PSN] · amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye] [SBD] · Pertzye (amylase 90,750 UNT / lipase 24,000 UNT / protease 86,250 UNT) Delayed Release Oral Capsule [SY] · Pertzye (amylases 90,750 UNT / endopeptidases 86,250 UNT / lipase 24,000 UNT) Delayed Release Oral Capsule [SY] | 4 | 22 | These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012 | 20240311 |